Gastrointestinal Cancer News

Patients with cancer who resided in low-income and rural areas appeared at higher risk for suicide than those in high-income and urban areas, according to a retrospective, population-based study in JAMA Network Open.

The FDA cleared an investigational new drug application for P-MUC1C-ALLO1, a chimeric antigen receptor T-cell therapy designed to treat adults with locally advanced or metastatic epithelial-derived solid tumors.

A select group of people who spend their day jobs fighting cancer — as surgical oncologists, radiation epidemiologists, or working in radiobiology and bionanotechnology — had a unique opportunity to lend their expertise to NASA.

Pancreatic cancer incidence increased among both men and women from 2000 to 2018, but researchers reported a greater relative increase among women aged younger than 55 years, according to study results published in JAMA.

Use of dietary supplements appeared common among adults who had been diagnosed with cancer, many of whom believed the supplements could lower the risk for disease recurrence despite a lack of proven benefit, according to a study in Cancer.

About one in four primary care clinicians surveyed preferred a stool-based test to a colonoscopy for colorectal cancer screening, according to findings published in Mayo Clinic Proceedings.

Sotorasib demonstrated antitumor activity among patients with heavily pretreated advanced KRAS G12C-mutated colorectal cancer, according to results of the phase 2 CodeBreak 100 trial published in The Lancet Oncology.

New data suggest that failure to achieve sustained virologic response after treatment with direct-acting antivirals for hepatitis C was a strong predictor for development of hepatocellular carcinoma.

Budesonide oral suspension improved histologic, endoscopic and symptom response compared with placebo among pediatric patients with eosinophilic esophagitis, according to a study.

Patients with hepatitis C virus have always carried an increased risk for developing hepatocellular carcinoma. Although antiviral treatment for HCV reduces that risk, it is not eliminated.